Mcdonagh, Luke ORCID: 0000-0003-2085-5404 (2021) Oxford University has a special responsibility to ensure jabs reach the Global South. LSE COVID-19 Blog (28 Apr 2021). Blog Entry.
Text (covid19-2021-04-28-oxford-university-has-a-special-responsibility-to)
- Published Version
Download (147kB) |
Abstract
Oxford University stands to make many millions from its vaccine spin-out. Yet the deals it has done, and the lack of a patent waiver, limit the ability of the Global South to manufacture AstraZeneca jabs. Luke McDonagh (LSE) argues that the university, as a wealthy and publicly funded institution, has a special responsibility to ensure the vaccine reaches countries where thousands of people are dying from COVID every day.
Item Type: | Online resource (Blog Entry) |
---|---|
Official URL: | https://blogs.lse.ac.uk/covid19/ |
Additional Information: | © 2021 The Author |
Divisions: | Law |
Subjects: | R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine H Social Sciences > HV Social pathology. Social and public welfare. Criminology |
Date Deposited: | 25 May 2021 13:51 |
Last Modified: | 11 Dec 2024 20:41 |
URI: | http://eprints.lse.ac.uk/id/eprint/110580 |
Actions (login required)
View Item |